Methodological considerations in neuronal extracellular vesicle isolation for α-synuclein biomarkers

Methodological considerations in neuronal extracellular vesicle isolation for α-synuclein biomarkers

Bibliografske podrobnosti
Main Authors:	Yan, S, Jiang, C, Davis, JJ, Tofaris, GK
Format:	Journal article
Jezik:	English
Izdano:	Oxford University Press 2023

Podobne knjige/članki

Neuronally derived extracellular vesicle α-synuclein as a serum biomarker for individuals at risk of developing Parkinson disease
od: Yan, S, et al.
Izdano: (2023)

Multiplexed profiling of extracellular vesicles for biomarker development
od: Jiang, C, et al.
Izdano: (2021)

Initiation and progression of α-synuclein pathology in Parkinson’s disease
od: Tofaris, GK
Izdano: (2022)

The Transcellular Propagation and Intracellular Trafficking of α-Synuclein
od: Tofaris, GK, et al.
Izdano: (2016)

Validation of α-synuclein in L1CAM-immunocaptured exosomes as a biomarker for the stratification of Parkinsonian syndromes
od: Jiang, C, et al.
Izdano: (2021)

Monitoring α-synuclein proteotoxicity in Drosophila models
od: Szabo, A, et al.
Izdano: (2019)

Extracellular vesicles in neurodegenerative disease — pathogenesis to biomarkers
od: Thompson, A, et al.
Izdano: (2016)

Modelling of the microglial response to neuronal α-synuclein aggregation
od: Katsikoudi, A
Izdano: (2022)

Methodological guidelines to study extracellular vesicles
od: Coumans, F, et al.
Izdano: (2017)

Phenotypic manifestation of α-synuclein strains derived from Parkinson’s disease and multiple system atrophy in human dopaminergic neurons
od: Tofaris, GK, et al.
Izdano: (2021)

ER stress and autophagic perturbations lead to elevated extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-derived dopamine neurons
od: Fernandes, H, et al.
Izdano: (2016)

α-Synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome
od: Tofaris, G, et al.
Izdano: (2001)

Investigating brain-derived α-synuclein fibrils and diagnostic biomarkers of synucleinopathies
od: Lee, S
Izdano: (2023)

Gut feelings about α-synuclein in gastrointestinal biopsies: biomarker in the making?
od: Ruffmann, C, et al.
Izdano: (2016)

α-synuclein genetic variability: A biomarker for dementia in Parkinson disease
od: Guella, I, et al.
Izdano: (2016)

Alternating magnetic field-promoted nanoparticle mixing: the on-chip immunocapture of serum neuronal exosomes for Parkinson’s disease diagnostics
od: Sharafeldin, M, et al.
Izdano: (2023)

Monitoring α-synuclein ubiquitination dynamics reveals key endosomal effectors mediating its trafficking and degradation
od: Zenko, D, et al.
Izdano: (2023)

Considerations and implications in the purification of extracellular vesicles -- a cautionary tale
od: Lee, YXF, et al.
Izdano: (2019)

New considerations in the preparation of nucleic acid-loaded extracellular vesicles.
od: Vader, P, et al.
Izdano: (2014)

Challenges associated with using extracellular vesicles as biomarkers in neurodegenerative disease
od: Couch, Y
Izdano: (2023)

Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity
od: Brekk, OR, et al.
Izdano: (2020)

Assessment of α-Synuclein Pathology
od: Alafuzoff, I, et al.
Izdano: (2008)

Studying α-Synuclein pathology using iPSC-derived dopaminergic neurons
od: Zambon, F
Izdano: (2017)

Contrasting effects of α-synuclein and γ-synuclein on the phenotype of cysteine string protein α (CSPα) null mutant mice suggest distinct function of these proteins in neuronal synapses.
od: Ninkina, N, et al.
Izdano: (2012)

How is alpha‐synuclein cleared from the cell?
od: Stefanis, L, et al.
Izdano: (2019)

REST protects dopaminergic neurons from mitochondrial and α-synuclein oligomer pathology in an alpha synuclein overexpressing BAC-transgenic mouse model
od: Ryan, BJ, et al.
Izdano: (2021)

Explaining the Structural Plasticity of α-Synuclein
od: Ullman, Orly, et al.
Izdano: (2012)

Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy
od: De Sousa, Karina P., et al.
Izdano: (2022)

Extracellular vesicles isolation using size exclusion chromatography in microfluidics
od: Neo, Benjamin Wen Hao
Izdano: (2021)

Physiological and pathological properties of alpha-synuclein.
od: Tofaris, G, et al.
Izdano: (2007)

Facile impedimetric analysis of neuronal exosome markers in Parkinson’s disease diagnostics
od: Tofaris, GK, et al.
Izdano: (2020)

Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra.
od: Garcia-Reitboeck, P, et al.
Izdano: (2013)

Extracellular vesicles in metabolic disease
od: Akbar, N, et al.
Izdano: (2019)

Alpha-synuclein dysfunction in Lewy body diseases.
od: Tofaris, G, et al.
Izdano: (2005)

Microfluidics approaches for label-free isolation of extracellular vesicles from blood
od: Leong, Sheng Yuan
Izdano: (2023)

Microfluidic isolation of extracellular vesicles using a short arcuated channel
od: Lim, Jia Jia
Izdano: (2022)

α-Synuclein and dopamine at the crossroads of Parkinson's disease.
od: Venda, L, et al.
Izdano: (2010)

A cross-sectional analysis of syncytiotrophoblast membrane extracellular vesicles–derived transcriptomic biomarkers in early-onset preeclampsia
od: Awoyemi, T, et al.
Izdano: (2023)

Loss of microRNA-7 regulation leads to α-synuclein accumulation and dopaminergic neuronal loss in vivo
od: McMillan, K, et al.
Izdano: (2017)

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons
od: Zambon, F, et al.
Izdano: (2019)